6-K 1 f6k_110513.htm FORM 6-K f6k_110513.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

___________________
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2013

Commission File Number: 001-34949
___________________

Tekmira Pharmaceuticals
(Translation of registrant's name into English)

100-8900 Glenlyon Parkway
Burnaby, British Columbia
Canada, V5J 5J8
 (Address of principal executive offices)
___________________


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [x]                                           Form 40-F [  ]
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  ___
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  ___
 
 
 

 
INCORPORATION BY REFERENCE
 
Exhibit 99.1 to this Form 6-K is hereby incorporated by reference as an exhibit to the registration statement on Form F-10 (File No. 333-185883) of Tekmira Pharmaceuticals Corporation.
 
DOCUMENTS FILED AS PART OF THIS FORM 6-K
 
 
See the Exhibit Index hereto.

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Tekmira Pharmaceuticals Corporation
   
   
Date: November 5, 2013
By:
/s/ BRUCE G. COUSINS
  Name: Bruce G. Cousins
  Title:
Executive Vice President and Chief Financial Officer
 
 
 

 
EXHIBIT INDEX
 
 
 
Exhibit
  
Description
99.1
  
Material Change Report, dated November 5, 2013